Evaluation of changes in renal function in PARAMOUNT: a phase III study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer

MLA

UCL - (SLuc) Service de pneumologie, et al. “Evaluation of Changes in Renal Function in PARAMOUNT: A Phase III Study of Maintenance Pemetrexed plus Best Supportive Care versus Placebo plus Best Supportive Care after Induction Treatment with Pemetrexed plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer.” Current Medical Research and Opinion, Vol. 34, No. 5, p. 865-871 (2018), 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1130441622&authtype=sso&custid=ns315887.

APA

UCL - (SLuc) Service de pneumologie, UCL - (SLuc) Centre du cancer, Ucl - Sss, I.-P. de P. O. et D., Middleton, G., Gridelli, C., De Marinis, F., Pujol, J.-L., Reck, M., Ramlau, R., Parente, B., Pieters, T., Visseren-Grul, C. M., San Antonio, B., John, W. J., Zimmermann, A. H., Chouaki, N., & Paz-Ares, L. (2018). Evaluation of changes in renal function in PARAMOUNT: a phase III study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer. Current Medical Research and Opinion, Vol. 34, No. 5, p. 865-871 (2018).

Chicago

UCL - (SLuc) Service de pneumologie, UCL - (SLuc) Centre du cancer, IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie Ucl - Sss, Gary Middleton, Cesare Gridelli, Filippo De Marinis, Jean-Louis Pujol, et al. 2018. “Evaluation of Changes in Renal Function in PARAMOUNT: A Phase III Study of Maintenance Pemetrexed plus Best Supportive Care versus Placebo plus Best Supportive Care after Induction Treatment with Pemetrexed plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer.” Current Medical Research and Opinion, Vol. 34, No. 5, p. 865-871 (2018). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1130441622&authtype=sso&custid=ns315887.